Tirzepatide, initially developed as a therapy for type 2 diabetes , has demonstrated impressive effectiveness in promoting slimming when administered. Distinct from many previous weight management medications , it works by targeting both hormones : GLP-1 and glucose-dependent insulinotropic polyp